Skip to main content

Published locations for Idelalisib use halted in six combo therapy trials, FDA announces

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Idelalisib use halted in six combo therapy trials, FDA announces

User login

  • Reset your password
  • /content/idelalisib-use-halted-six-combo-therapy-trials-fda-announces
  • /hematologynews/article/107362/indolent-lymphoma/idelalisib-use-halted-six-combo-therapy-trials-fda
  • /oncologypractice/article/107362/indolent-lymphoma/idelalisib-use-halted-six-combo-therapy-trials-fda
  • /hematologynews/nhlhub/article/107362/indolent-lymphoma/idelalisib-use-halted-six-combo-therapy
  • /hematology-oncology/article/107362/indolent-lymphoma/idelalisib-use-halted-six-combo-therapy-trials
  • /b-cell-lymphoma-icymi/article/107362/indolent-lymphoma/idelalisib-use-halted-six-combo-therapy